Pihlajalinna Plc publishes Half-year Report for January 1–June 30, 2023 on Friday, 11 August, 2023
Pihlajalinna Plc Investor News 31 July 2023 at 10:00 a.m.
Pihlajalinna Plc publishes Half-year Report for January 1–June 30, 2023 on Friday, 11 August, 2023
Pihlajalinna Plc will publish the Half-year Report for the period of January 1–June 30, 2023 on Friday, 11 August, 2023 at approximately 8.00 a.m. The release will be available on the company website.
Live webcast for analysts, investors and media
Pihlajalinna will organize a live webcast meeting for analysts, investors and media on Friday, 11 August, 2023 at 10:00 a.m. at https://pihlajalinna.videosync.fi/q2-2023.
Financial results will be presented by the interim CEO Mikko Wirén. The event will be conducted in Finnish.
Participation is also possible on site at Studio Stage (Ruoholahti), Itämerentori 2, 00180 Helsinki. The space has a limited number of seats, so please register by e-mail to viestinta@pihlajalinna.fi by Monday, 7 August, 2023.
The recording of the event will be available later on the same webpage as the live webcast.
Pihlajalinna Plc
Further information:
Tarja Rantala, CFO, +358 40 774 9290, tarja.rantala@pihlajalinna.fi
Tuula Lehto, Vice President, Communications and Sustainability, +358 40 588 5343, tuula.m.lehto@pihlajalinna.fi
Distribution:
Key media
investors.pihlajalinna.fi
Pihlajalinna in brief
Pihlajalinna is one of the leading providers of private healthcare and wellbeing services in Finland. The Group produces doctor's appointment services and specialised care, occupational healthcare services and residential and welfare services. To public entities Pihlajalinna offers social and healthcare service production models, in which the cooperation between the public and private sectors guarantees high-quality services for citizens. In 2022, Pihlajalinna's revenue was 690.5 million euros. More than 7,000 employees and 2,000 practitioners work at Pihlajalinna. Pihlajalinna's shares are listed on Nasdaq Helsinki Oy. Read more www.pihlajalinna.fi.